Role of Cancer Cell-stroma Interaction in Invasive Growth of Cancer Cells

Overview

Journal Hum Cell

Publisher Springer

Specialty Cell Biology

Date 2003 Sep 16

PMID 12971620

Citations 14

Authors

Hiroaki Kataoka

Hiroyuki Tanaka

Koki Nagaike

Shuichiro Uchiyama

Hiroshi Itoh

Affiliations

Soon will be listed here.

Abstract

Invasive growth is one of the hallmarks of cancer malignancy. To date, a significant body of evidence is accumulating in favor of the notion that invasive growth results from the cross-talk between cancer cells and the host stromal cells, comprising fibroblasts (myofibroblasts), endothelial cells, and leukocytes, all of which are themselves invasive. In this review we describe cross-talk between invasive cancer cells and host stromal fibroblasts and an impact of pericellular microenvironment on the invasive phenotype of cancer cells, focusing on two molecules, extracellular matrix metalloproteinase inducer (EMMPRIN, also known as tumor cell-derived collagenase stimulatory factor, basigin, CD147) and hepatocyte growth factor (HGF, also known as scatter factor). Both molecules are deeply involved in the regulation of invasion-associated cellular activities, such as pericellular proteolysis, migration and ectopic survival of cancer cells.

Citing Articles

Significance of Biogenetic Markers in Giant Cell Tumor Differentiation and Prognosis: A Narrative Review.

Taqi M, Ul Rasool H, Zaka Haider M, Al Muderis M Diagnostics (Basel). 2025; 15(1.

PMID: 39795567 PMC: 11719472. DOI: 10.3390/diagnostics15010039.

Peritoneal Metastasis: A Dilemma and Challenge in the Treatment of Metastatic Colorectal Cancer.

Xia W, Geng Y, Hu W Cancers (Basel). 2023; 15(23).

PMID: 38067347 PMC: 10705712. DOI: 10.3390/cancers15235641.

Dysregulation of Type II Transmembrane Serine Proteases and Ligand-Dependent Activation of MET in Urological Cancers.

Mukai S, Yamasaki K, Fujii M, Nagai T, Terada N, Kataoka H Int J Mol Sci. 2020; 21(8).

PMID: 32290402 PMC: 7215454. DOI: 10.3390/ijms21082663.

Targeted matrisome analysis identifies thrombospondin-2 and tenascin-C in aligned collagen stroma from invasive breast carcinoma.

Tomko L, Hill R, Barrett A, Szulczewski J, Conklin M, Eliceiri K Sci Rep. 2018; 8(1):12941.

PMID: 30154546 PMC: 6113240. DOI: 10.1038/s41598-018-31126-w.

Establishment and Characterization of Paired Primary and Peritoneal Seeding Human Colorectal Cancer Cell Lines: Identification of Genes That Mediate Metastatic Potential.

Kim S, Hong C, Jang S, Kim Y, Yoo B, Shin Y Transl Oncol. 2018; 11(5):1232-1243.

PMID: 30114595 PMC: 6097464. DOI: 10.1016/j.tranon.2018.07.014.

References

Abounader R, Ranganathan S, Lal B, Fielding K, Book A, Dietz H . Reversion of human glioblastoma malignancy by U1 small nuclear RNA/ribozyme targeting of scatter factor/hepatocyte growth factor and c-met expression. J Natl Cancer Inst. 1999; 91(18):1548-56. DOI: 10.1093/jnci/91.18.1548. View

Gohda E, Tsubouchi H, Nakayama H, Hirono S, Sakiyama O, Takahashi K . Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure. J Clin Invest. 1988; 81(2):414-9. PMC: 329584. DOI: 10.1172/JCI113334. View

Shimomura T, Kondo J, Ochiai M, Naka D, Miyazawa K, Morimoto Y . Activation of the zymogen of hepatocyte growth factor activator by thrombin. J Biol Chem. 1993; 268(30):22927-32. View

Matsubara Y, Ichinose M, Yahagi N, Tsukada S, Oka M, Miki K . Hepatocyte growth factor activator: a possible regulator of morphogenesis during fetal development of the rat gastrointestinal tract. Biochem Biophys Res Commun. 1999; 253(2):477-84. DOI: 10.1006/bbrc.1998.9808. View

Taylor P, Woodfield R, Hodgkin M, Pettitt T, Martin A, Kerr D . Breast cancer cell-derived EMMPRIN stimulates fibroblast MMP2 release through a phospholipase A(2) and 5-lipoxygenase catalyzed pathway. Oncogene. 2002; 21(37):5765-72. DOI: 10.1038/sj.onc.1205702. View

Lin C, Anders J, Johnson M, Dickson R . Purification and characterization of a complex containing matriptase and a Kunitz-type serine protease inhibitor from human milk. J Biol Chem. 1999; 274(26):18237-42. DOI: 10.1074/jbc.274.26.18237. View

Kawaguchi T, Qin L, Shimomura T, Kondo J, Matsumoto K, Denda K . Purification and cloning of hepatocyte growth factor activator inhibitor type 2, a Kunitz-type serine protease inhibitor. J Biol Chem. 1997; 272(44):27558-64. DOI: 10.1074/jbc.272.44.27558. View

Itoh H, Hamasuna R, Kataoka H, Yamauchi M, Miyazawa K, Kitamura N . Mouse hepatocyte growth factor activator gene: its expression not only in the liver but also in the gastrointestinal tract. Biochim Biophys Acta. 2000; 1491(1-3):295-302. DOI: 10.1016/s0167-4781(00)00029-4. View

van Adelsberg J, Sehgal S, Kukes A, Brady C, Barasch J, Yang J . Activation of hepatocyte growth factor (HGF) by endogenous HGF activator is required for metanephric kidney morphogenesis in vitro. J Biol Chem. 2000; 276(18):15099-106. DOI: 10.1074/jbc.M006634200. View

10.

Trusolino L, Comoglio P . Scatter-factor and semaphorin receptors: cell signalling for invasive growth. Nat Rev Cancer. 2002; 2(4):289-300. DOI: 10.1038/nrc779. View

11.

Hayashi T, Abe K, Sakurai M, Itoyama Y . Inductions of hepatocyte growth factor and its activator in rat brain with permanent middle cerebral artery occlusion. Brain Res. 1998; 799(2):311-6. DOI: 10.1016/s0006-8993(98)00391-6. View

12.

Schmidt L, Duh F, Chen F, Kishida T, Glenn G, Choyke P . Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nat Genet. 1997; 16(1):68-73. DOI: 10.1038/ng0597-68. View

13.

Takeuchi T, Harris J, Huang W, Yan K, Coughlin S, Craik C . Cellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and single-chain urokinase-type plasminogen activator as substrates. J Biol Chem. 2000; 275(34):26333-42. DOI: 10.1074/jbc.M002941200. View

14.

Kataoka H, Itoh H, Hamasuna R, Meng J, Koono M . Pericellular activation of hepatocyte growth factor/scatter factor (HGF/SF) in colorectal carcinomas: roles of HGF activator (HGFA) and HGFA inhibitor type 1 (HAI-1). Hum Cell. 2001; 14(1):83-93. View

15.

Oberst M, Johnson M, Dickson R, Lin C, Singh B, Stewart M . Expression of the serine protease matriptase and its inhibitor HAI-1 in epithelial ovarian cancer: correlation with clinical outcome and tumor clinicopathological parameters. Clin Cancer Res. 2002; 8(4):1101-7. View

16.

Mars W, Zarnegar R, Michalopoulos G . Activation of hepatocyte growth factor by the plasminogen activators uPA and tPA. Am J Pathol. 1993; 143(3):949-58. PMC: 1887222. View

17.

Liotta L, Kohn E . The microenvironment of the tumour-host interface. Nature. 2001; 411(6835):375-9. DOI: 10.1038/35077241. View

18.

Rahimi N, Tremblay E, McAdam L, Park M, Schwall R, Elliott B . Identification of a hepatocyte growth factor autocrine loop in a murine mammary carcinoma. Cell Growth Differ. 1996; 7(2):263-70. View

19.

Sternlicht M, Werb Z . How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol. 2001; 17:463-516. PMC: 2792593. DOI: 10.1146/annurev.cellbio.17.1.463. View

20.

Miyazawa K, Shimomura T, Kitamura A, Kondo J, Morimoto Y, Kitamura N . Molecular cloning and sequence analysis of the cDNA for a human serine protease reponsible for activation of hepatocyte growth factor. Structural similarity of the protease precursor to blood coagulation factor XII. J Biol Chem. 1993; 268(14):10024-8. View